$Novavax(NVAX)$NVAX stock moves higher on the news that its highly anticipated Covid-19 vaccine has been approved for use in American adults.
With the blessing of regulators, Novavax must now move to mass produce the vaccine and sell it around the country and wider world. While the company has cleared one important hurdle, it now moves onto new challenges.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments